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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe increased incidence of obesity and metabolic disease underscores the importance of elucidating the biology of adipose tissue devel-
opment. The recent discovery of cell surface markers for prospective identification of adipose precursor cells (APCs) in vivo will greatly
facilitate these studies, yet tools for specifically targeting these cells in vivo have not been identified. Here, we survey three transgenic
mouse lines, Fabp4-Cre, PdgfRa-Cre, and Prx1-Cre, precisely assessing Cre-mediated recombination in adipose stromal populations and
mature tissues. Our data provide key insights into the utility of these tools to modulate gene expression in adipose tissues. In particular,
Fabp4-Cre is not effective to target APCs, nor is its activity restricted to these cells. PdgfRa-Cre directs recombination in the vastmajority of
APCs, but also targets other populations. In contrast, adipose expression of Prx1-Cre is chiefly limited to subcutaneous inguinal APCs,
which will be valuable for dissection of APC functions among adipose depots.INTRODUCTION
Adipose precursor cells (APCs) are a subpopulation of line-
age (Lin)SCA1+ adipose-derived stromal cells competent
to undergo adipogenesis in vivo and generate a functional
adipose depot after transplantation (Rodeheffer et al.,
2008; Joe et al., 2009; Schulz et al., 2011). It is widely antic-
ipated that these cells will have an important role in regen-
erative medicine (Ong and Sugii, 2013). Furthermore, the
recent isolation and characterization of APCs from white
adipose tissue (WAT) using cell surface markers (Rodeheffer
et al., 2008) open new avenues of stem cell and metabolic
research. These markers can be used to quantify precursor
cells within the adipose depot or to isolate cells for trans-
plant or ex vivo assays (Rodeheffer et al., 2008; Joe et al.,
2010; Schulz et al., 2011; Berry and Rodeheffer, 2013).
However, it would be of great utility to manipulate gene
expression in APCs in their physiologic in vivo context.
Such experiments would require the identification of pro-
moter/enhancer sequences that can direct gene expression
specifically to this population. Previously, the promoter
regions of several genes expressed inmesenchymal progen-
itors have been isolated and their activity characterized
(Logan et al., 2002; Roesch et al., 2008; Berry and Rode-
heffer, 2013). These regulatory elements, when used to
drive expression of Cre recombinase, may be useful for
genetic manipulation of APCs.
Here we analyze recombination directed by several Cre
lines in stromal populations ofWATand brown adipose tis-
sue (BAT). We find that the most commonly used line to
direct adipose-specific expression, Fabp4-Cre (He et al.,
2003), is not active in most WAT APCs. We confirm previ-Stem Cell Repous studies that PdgfRa-Cre (Roesch et al., 2008) is active
in most WAT APCs (Berry and Rodeheffer, 2013) and also
find activity in most BAT LinSCA1+ cells. However,
we also detect activity in other adipose stromal cells. In
contrast, a line previously reported to direct expression
in uncommitted mesenchymal progenitors (Calo et al.,
2010), Prx1-Cre, has activity restricted to adipose precursors
of the subcutaneous inguinal fat pad,with little recombina-
tion in other cell types within the fat pads examined.
Together, these data serve as a guide for the use of these
tools in the manipulation of gene expression in adipose
tissues in vivo.RESULTS
The stromal compartment of adipose depots includes lym-
phocytes, macrophages, endothelial cells (ECs), fibroblasts,
and APCs and, when isolated from adipocytes, is collec-
tively referred to as the stromal vascular fraction (SVF) (San-
chez-Gurmaches and Guertin, 2014). Using a combination
of four markers (CD45, CD11b, CD31, and SCA1), SVF cells
can be categorized into five populations (Figures 1A and
1B), including APCs (CD45CD11bCD31SCA1+). In cul-
ture, these isolated LinSCA1+ cells are highly responsive
to standard adipogenic induction cocktail (Figure 1C and
Figure S1A available online). Although cells from BAT
with the APC marker profile differentiate ex vivo (San-
chez-Gurmaches et al., 2012) and express markers of BAT
(Schulz et al., 2011; Liu et al., 2013), these cells are less
well studied than WAT APCs; therefore, we refer to these
as LinSCA1+ cells. Cells not labeled by any of the cellorts j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 The Authors 1147
Figure 1. Flow Cytometry Schema to Profile Adipose Stromal Cells and Validation by Ex Vivo Differentiation
(A) Flow cytometry schema of adipose stromal cell types using combinations of cell surface markers, applied to all Cre;Rosa-EYFP adipose
depots.
(B) Representative flow cytometry plots of inguinal WAT live cells. (Left panel) Plot of live cells stained with CD45 (PE-Cy7) and CD11b
(APC-Cy7). (Middle panel) Plot of CD45CD11b cells stained with SCA1 (Pacific Blue) and CD31 (APC). (Right panel) Histogram of EYFP
fluorescence within APCs (LinSCA1+). Label above plots indicates parent populations.
(C) iWAT APCs cultured in growth media (left) or adipogenic induction media (right), shown 6 days after induction. Scale bar represents
0.5 mm.
See also Figure S1.
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after referred to as SCA1CD31 cells) are heterogeneous in
size and morphology (Figures S1B and S1C). In order to1148 Stem Cell Reports j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 Ththoroughly document expression in all stromal cells, we
report the recombination data (as in Figure S1D) but have
not further characterized this population.e Authors
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of specific targeting APCs in vivo, mice carrying the Cre re-
combinase-responsive Enhanced Yellow Fluorescent Protein
(EYFP) allele in the Rosa locus (Rosa-EYFP) (Srinivas et al.,
2001) were crossed to one of three Cre lines. These lines
were chosen for their common usage in studies of adipose
tissue (Fabp4-Cre) (Mullican et al., 2013; Berry et al.,
2014) or because of previous reports of activity of these
Cre lines in adipose or mesenchymal progenitors (PdgfRa-
Cre, Prx1-Cre) (Calo et al., 2010; Lee et al., 2012; Berry
and Rodeheffer, 2013). The flow cytometry analysis
scheme (Figure 1A) was applied to the SVF of fat pads
from Cre;Rosa-EYFP double transgenic mice.
Fabp4-Cre
The Fabp4 (also called aP2) promoter is a widely used tool
to direct adipose-specific gene expression and, when used
to direct Cre recombinase, adipose-specific gene deletion
(Mullican et al., 2013; Berry et al., 2014). Multiple Fabp4-
Cre lines have been generated (Barlow et al., 1997; Abel
et al., 2001; He et al., 2003; Tang et al., 2008), but the
line described by He et al. (2003) is most commonly used
(Mullican et al., 2013). Despite confirmation of Fabp4-Cre
activity in adipose tissues, prior studies did not quantita-
tively assess the expression of Fabp4-Cre in adipose stromal
cells or specifically in APCs in vivo. We analyzed the SVF of
subcutaneous inguinal and gonadalWAT (iWATand gWAT,
respectively) and of interscapular BAT from male Fabp4-
Cre;Rosa-EYFP mice by flow cytometry. We found that
Fabp4-Cre directs low levels of recombination in WAT
APCs, ranging from 15% in iWAT to 20% in gWAT (Fig-
ure 2A). However,41% of BAT LinSCA1+ cells are recom-
bined (Figure 2A). In contrast, EYFP expression is observed
in 23%–38% of ECs of BAT and WAT. Fapb4-Cre directs
modest levels of recombination in SCA1CD31 cells
(6%–7% across depots) and macrophages (7%–13% across
depots), with very few nonmacrophage white blood cells
(CD45+CD11b) expressing EYFP (Figure 2A). Similar re-
sults were obtained when female mice were examined
(Figure 2B).
The low levels of recombination observed in iWAT APCs
led us to wonder about the properties of those select APCs
in which Fabp4-Cre is active. First, we evaluated gene
expression in iWAT APCs for markers of more committed
preadipocytes. Interestingly, cells in which Fabp4-Cre is
active (EYFP+) express higher levels of Fabp4 and Pparg as
compared with EYFP cells (Figure S2A). These findings
are consistent with the EYFP+ cells being more differenti-
ated than the EYFP cells. Next, we considered whether
these recombined cells are more adipogenic than nonre-
combined cells. EYFP+ and EYFP iWAT APCs were sorted,
cultured, and induced to differentiate using standard in-
duction cocktail. Both populations differentiated equallyStem Cell Repwell (Figure S2B), indicating that adipogenic capability, at
least ex vivo, does not correlate exclusively with Fabp4-
Cre activity.
Fabp4 is expressed at low levels in undifferentiated SVF in
culture, but rapidly increases its expression with adipogen-
esis and is highly expressed in mature adipocytes (Shan
et al., 2013). We therefore hypothesized that adipogenic
differentiation would increase Fabp4-Cre-mediated recom-
bination. Both SVF and bone marrow stromal cell (BMSC)
cultures contain preadipocytes and are commonly used as
ex vivo models of adipogenesis. We monitored Fabp4-Cre
recombinase activity in cultured iWAT SVF and BMSCs
from Fabp4-Cre;Rosa-EYFP mice. In undifferentiated cells,
20% of SVF and 1% of BMSCs expressed EYFP (Fig-
ure 2C, left panels). Strikingly, following adipogenic induc-
tion, 80% of the SVF-derived adipocytes are EYFP+, but
far fewer (52%) of the BMSC-derived adipocytes appear
recombined (Figure 2C, right panels). Thus, Fabp4-Cre
labeling of adipose precursors and adipocytes is depot
dependent.
To monitor Fabp4-Cre-mediated recombination in vivo,
adipose tissues were fixed, sectioned, and stained for
EYFP and markers of adipocytes (perilipin) or ECs (CD31).
Since there is green autofluorescence in adipose tissues, sin-
gle transgenic controls were processed and stained along-
side double transgenic tissues for comparison (Figure S2C).
As expected, immunostaining of adipose tissue revealed
many EYFP+ adipocytes in both WAT and BAT (Figure 2D),
although some adipocytes appear unlabeled (Figure 2D,
arrows). We also observed perilipin structures clearly
labeled with EYFP (Figure 2D, arrowheads), some of which
are ECs (Figure 2E). Importantly, CD31+ structures in mus-
cle are also colabeled with EYFP (Figure 2E). Consistent
with the findings of others (Mora´n-Salvador et al., 2013;
Mullican et al., 2013), we also detect widespread recom-
bined cells in the liver and intestine (Figure S2D). Together,
these results demonstrate that Fabp4-Cre is expressed in
many but not all adipocytes, is not restricted to the adipose
lineage, and is not specific to adipose tissues.
PdgfRa-Cre
PdgfRa is expressed in many cells of neuroectodermal or
mesenchymal origin, including oligodendrocyte precur-
sors (Rivers et al., 2008), neural crest cells (Soriano, 1997),
the developing intestine (Karlsson et al., 2000), testes
(Brennan et al., 2003), and heart (Chong et al., 2011) and
may alsomark bonemarrowmesenchymal stem cells (Mor-
ikawa et al., 2009). A mouse in which Cre is directed by
PdgfRa regulatory elements (Roesch et al., 2008) was shown
to label WAT APCs when combined with other cell surface
markers (Berry and Rodeheffer, 2013). Consistent with
these latter findings, our analysis of PdgfRa-Cre;Rosa-EYFP
mice suggests that Cre is active in nearly all (96%–99%)orts j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 The Authors 1149
Figure 2. Fabp4-Cre Recombinase Activity in Adipose Stromal Populations, Culture, and Tissue Sections
(A) Flow cytometry profile of Fabp4-Cre;Rosa-EYFP male mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.
(B) Flow cytometry profile of Fabp4-Cre:Rosa-EYFP female mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.
(C) Expression of EYFP in cultured cells, prior to or after adipogenic induction. The estimated percentage of EYFP+ cells or adipocytes is
indicated. Scale bar represents 0.2 mm.
(legend continued on next page)
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(89%) BATLinSCA1+ cells are also recombined (Figure 3A).
Moreover, we observe that PdgfRa-Cre activity in iWAT is
specific for APCs, as only low levels of recombination
(<11%) are detected in white blood cells and ECs. However,
PdgfRa-Cre induces recombination in 56% of SCA1CD31
cells in gWAT (Figure 3A). Thus, while this Cre line effec-
tively targets the vast majority of APCs, it is clearly not
exclusive to this cell type across adipose depots. Similar re-
sults were obtained when female mice were examined (Fig-
ure 3B). In agreement with previous reports of endogenous
PdgfRa expression (Morikawa et al., 2009) and in contrast
to Fabp4-Cre, PdgfRa-Cre also directs expression to most
BMSC preadipocytes, as evidenced by the large fraction of
EYFP+ adipocytes generated following adipogenic induc-
tion (Figure 3C).
Imaging of histological sections of WAT from PdgfRa-
Cre;Rosa-EYFP animals confirms the flow cytometry results,
as a high level of recombination in adipocytes is observed
(Figure 3D). Interestingly, not all brown adipocytes are
EYFP+, perhaps reflecting the slightly lower recombination
in BAT LinSCA1+ cells versus WAT APCs (Figures 3A and
3D, arrow).We also noted recombination in cells surround-
ing CD31+ ECs (Figure 3E). This finding is intriguing in
light of other reports of adipose progenitor cells associated
with blood vessels as part of a perivascular niche (Tang
et al., 2008). In contrast to Fabp4-Cre, very few EYFP+ cells
were detected in muscle sections from PdgfRa-Cre;Rosa-
EYFPmice, and most of these are intramuscular adipocytes
(Figure 3F). These studies show that PdgfRa-Cre is highly
active in, but not limited to, APCs of adipose lineages.Prx1-Cre
Prx1-Cre directs expression to the embryonic limb bud
mesenchyme, flank mesoderm, and a subset of the cranial
mesenchyme (Logan et al., 2002), as well as to uncommit-
ted mesenchymal progenitors of several other tissues (Calo
et al., 2010). Therefore, it was expected that recombination
would be observed in many SVF cells of all adipose depots.
However, in striking contrast to the other Cre lines exam-
ined, adipose Prx1-Cre activity is mostly restricted to
iWAT APCs: we observed recombination in >82% of APCs
in both males and females (Figures 4A and 4B). Intrigu-
ingly, modest recombination is observed in gWAT APCs
of female mice (18%), as well as in SCA1CD31 cells of
either depot (14%–22%) (Figure 4B), but is absent in males
(Figure 4A). Neither sex displays significant recombination(D) Expression of EYFP and perilipin (red), a marker of adipocyte
adipocytes. Arrowheads indicate putative endothelial structures labe
(E) Expression of EYFP and CD31 (red) in sections of adipose tissue o
Mac, macrophage. See also Figure S2.
Stem Cell Repin any BAT SVF cell type (Figures 4A and 4B). Thus, Prx1-Cre
has unexpected specificity for APCs, and this is particularly
evident inmalemice. As expected, examination of cultured
iWAT SVF or BMSCs revealed a strikingly high percentage
of recombination, both prior to and after adipogenic induc-
tion (Figure 4C), which is consistent with previous data
showing recombination in limb bud mesenchyme (Logan
et al., 2002).
In sections of iWAT, nearly all perilipin+ cells also express
EYFP (Figure 5A, left). Also consistent with the flow cytom-
etry results, there are very few EYFP+ cells in BAT or gWAT
sections from male mice (Figure 5A, right). However,
in agreement with the Cre activity detected in APCs,
there are perilipin+EYFP+ cells in female gWAT (Figure 5B).
Similar to our results with PdgfRa-Cre;Rosa-EYFP mice and
in contrast to our observations of Fabp4-Cre;Rosa-EYFP
iWAT, some EYFP+ cells in Prx1-Cre;Rosa-EYFP iWAT
surround but do not overlap with CD31+ cells (Figure 5C,
upper panel).
Interestingly, stainingofmuscle tissue reveals recombina-
tion in a number of adipocytes, as well as in scattered
CD31 cells (Figure 5C, lower panel). However, EYFP
expression is not detectable in the myofibers, suggesting
cells expressing the Prx1-Cre transgene do not contribute
to themuscle lineage, even thoughmuscle progenitors arise
from mesenchymal stem cells (Calo et al., 2010). Rare cells
showing recombinationare alsodetected in the liver and in-
testine of Prx1-Cre;Rosa-EYFPmice (Figure S3). In summary,
our findings suggest that Prx1-Cre has a surprisingly
restricted expression pattern in adipose and other tissues
and a high degree of specificity for APCs in the iWAT.DISCUSSION
Recent studies have elucidated surface markers that can be
used to distinguish and isolate APCs in adipose tissue from
other stromal cell populations (Rodeheffer et al., 2008).
However, continued progress in the field relies on the iden-
tificationof tools for targetedmanipulationofAPCs in vivo.
In this study, we assessed the ability of different Cre mouse
lines to target APCs relative to other adipose stromal popu-
lations. While prior studies have examined recombination
in selected stromal cells directed by either Fabp4-Cre (Shan
et al., 2013) or PdgfRa-Cre (Berry and Rodeheffer, 2013),
here we provide a quantitative report of in vivo Cre recom-
binase activity in all stromal populations of WAT and BAT
depots.s, in sections of adipose tissue. Arrows indicate nonrecombined
led by EYFP. Scale bar represents 0.1 mm.
r skeletal muscle. Scale bar represents 0.1 mm.
orts j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 The Authors 1151
(legend on next page)
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Figure 4. Prx1-Cre Recombinase Activity in Adipose Stromal Populations and in Cultured Cells
(A) Flow cytometry profile of Prx1-Cre;Rosa-EYFP male mice (n = 3), where each n is one animal.
(B) Flow cytometry profile of Prx1-Cre;Rosa-EYFP female mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.
(C) Expression of EYFP in cultured cells, prior to or after adipogenic induction. The estimated percentage of EYFP+ cells or adipocytes is
indicated. Scale bar represents 0.2 mm.
Mac, macrophage.
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by the various Cre lines reveals important distinctions. In
particular, the most widely used line for directing adi-Figure 3. PdgfRa-Cre Recombinase Activity in Adipose Stromal Po
(A) Flow cytometry profile of PdgfRa-Cre;Rosa-EYFP male mice (n = 3)
(B) Flow cytometry profile of PdgfRa-Cre;Rosa-EYFP female mice (n = 3
(C) Expression of EYFP in cultured BMSCs, prior to or after adipoge
indicated. Scale bar represents 0.2 mm.
(D) Expression of EYFP and perilipin (red) in sections of WAT and BAT
putative vascular structures labeled by EYFP. Scale bar represents 0.1
(E) Expression of EYFP and CD31 (red) in sections of adipose tissue.
(F) Expression of EYFP and perilipin (red) in skeletal muscle. Scale ba
Mac, macrophage. See also Figure S3.
Stem Cell Reppose-specific recombination, Fabp4-Cre, is poorly suited
to target APCs. A previous study of Fabp4-Cre;Rosa-TdTo-
mato mice reported substantially higher numbers ofpulations and in Tissue Sections
, where each n is one animal. Data are represented as mean ± SEM.
), where each n is one animal. Data are represented as mean ± SEM.
nic induction. The estimated percent EYFP+ cells or adipocytes is
. Arrows indicate nonrecombined adipocytes. Arrowheads indicate
mm.
Scale bar represents 0.1 mm.
r represents 0.1 mm.
orts j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 The Authors 1153
Figure 5. Prx1-Cre Recombinase Activity in Tissue Sections
(A) Expression of EYFP and perilipin (red) in sections of male WAT and BAT. Arrowheads indicate putative ECs labeled by EYFP. Scale bar
represents 0.1 mm.
(B) Expression of EYFP and perilipin (red) in sections of gonadal tissue from male and female mice. Scale bar represents 0.1 mm.
(C) Expression of EYFP and CD31 (red) in sections of male iWAT and skeletal muscle. Scale bar represents 0.1 mm.
Mac, macrophage; gWAT, gonadal (epididymal or parametrial for male or female, respectively) WAT. See also Figure S4.
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In Vivo Targeting of Adipocyte Precursor Cellsrecombined precursors (60% in bothWATand BAT) than
reported here, using the same cell surface marker profile
(Shan et al., 2013). However, Shan and colleagues evalu-
ated cells that were cultured after sorting, whereas in our
study, the EYFP reporter expression is quantified in vivo.
Fabp4-Cre is neither active in the majority of APCs of any
depot, nor is it specific for APCs: other stromal cells types,
particularly ECs, display similar or even higher levels of
recombination (Figures 2A and 2B). Since Fabp4 expression
increases with adipogenic differentiation, it is plausible
that the Fabp4-Cre recombination of APCs marks a more
committed subset of cells (Liu et al., 2013), although addi-
tional studies are required to substantiate this hypothesis.
Despite low levels of recombination in APCs, substantial
activity of Fabp4-Cre is apparent in mature adipose tissues,
consistent with the initial characterization (He et al.,
2003), and this should contribute to the phenotypes
observed in studies that utilize this promoter. However,
the lack of fidelity to the adipose lineage is clear, as recombi-
nationhas beendetected inmuscle and liver (Figures 2E and
S2D, respectively; Mora´n-Salvador et al., 2013; Mullican
et al., 2013), embryonic limb bud and dorsal root ganglion
(Urs et al., 2006), adrenal medulla and brain (Martens
et al., 2010), and other tissues (Mullican et al., 2013). These
other sites of expression could be a feature of this particular
transgenic line, but analysis of another independently
generated Fabp4-Cre line (Abel et al., 2001) also identified
many nonadipose sites of recombination (Lee et al., 2013).
Together, these findings suggest that Fabp4-Cre is not a suit-
able tool for effective and specific targeting of APCs.
In contrast to Fabp4-Cre, PdgfRa-Cre is highly active in
both WAT and BAT LinSCA1+ cells, demonstrating the
highest recombination efficiency among all examined
Cre lines. However, we observed PdgfRa-Cre activity in
other stromal populations (Figures 3A–3C). While further
evaluation will be required, the expression of Cre in other
lineages could confound the results of in vivo experiments
utilizing this line to study adipose tissue biology. The
PdgfRa-Cre line characterized here was generated using a
large genomic fragment, from a bacterial artificial chromo-
some, in an effort to capture the regulatory elements
required for the complex endogenous PdgfRa expression
pattern (Zhang et al., 1998). However, it would be highly
useful to isolate regulatory elements for particular progen-
itor populations. Such findings should allow more precise
targeting of each cell group and may inform the lineage
hierarchy among progenitors.
Surprisingly, we discovered that among adipose depots,
Prx1-Cre activity is specific for iWAT APCs, particularly in
male mice. These results were unexpected, given a prior
study that reported widespread recombination in both
WAT and BAT, purportedly due to recombination at the
progenitor stage (Calo et al., 2010). However, that studyStem Cell Reputilized a different indicator line, Rosa-lacZ (Soriano,
1999), and did not quantify recombination or determine
the identity of the cells in which recombination was de-
tected. Here, we comprehensively examine stromal cells
from multiple depots and quantify recombination in vivo
in defined cell populations. These findings are consistent
with the immunostaining results of adipose tissues: high
levels of recombination in iWAT, much less in gWAT, and
little to no recombination in BAT. Finally, previous work
has shown the same Cre allele can direct different expres-
sion patterns depending on the mouse strain background
(He´bert and McConnell, 2000). The mice utilized in our
study were maintained in the C57BL/6 background,
whereas the prior study utilized a mixed genetic back-
ground (Calo et al., 2010). Therefore, some differences in
recombination observed between these studies may be
the result of background modifiers of Prx1-Cre expression.
Our studies do not address whether this recombination
pattern reflects physiological expression of Prx1, the activ-
ity of isolated Prx1 promoter elements, or results from chro-
mosomal positional effects of this particular transgenic
line. The documented expression of Prx1-Cre in the limb
bud (Logan et al., 2002) and our own studies of bone
marrow cultures (Figure 4C) suggest that experiments
with these mice will require careful interpretation. How-
ever, for the study of genes primarily essential to adipose
tissue function, our results highlight the utility of Prx1-
Cre over PdgfRa-Cre, as the restricted activity of the former
within adipose depots allows for the study of gene function
specifically in iWAT APCs. Previous studies in mice have
shown that iWAT transplanted into the visceral cavity is
metabolically protective, resulting in decreased overall fat
mass, improved glucose homeostasis, and insulin sensi-
tivity, although the reasons for these benefits are not well
understood (Tran et al., 2008). The specificity of Prx1-Cre
activity could enable the identification of genes respon-
sible for these and other known functional differences
among fat depots, including gene expression, adipokine
release, APC proliferation, and lipid homeostasis (Tchkonia
et al., 2013). Interestingly, another recently characterized
Cre line is active in various visceral adipose depots,
including gWAT, but not in iWAT or BAT (Chau et al.,
2014), and thus will be a useful complementary tool to
analyze alongside Prx1-Cre-directed recombination.
Finally, inducible (Cre-ER) versions of these lines have
been generated using the sameor similar promoter elements
(Imai et al., 2001; Rivers et al., 2008; Kawanami et al., 2009;
Kang et al., 2010). However, even if the same genomic se-
quences are used, the unique integration site of each trans-
genic line and mouse genetic background will likely alter
the Cre expression pattern from what is reported here. We
would recommend that investigators employing these and
other lines evaluate the expression patterns to assess theorts j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 The Authors 1155
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worthwhile to examine whether increased temporal resolu-
tion can further restrict the Cre activity and thus increase
their specificity for defined target populations.EXPERIMENTAL PROCEDURES
Mouse Models
All studies were approved by Stanford University’s Administrative
Panel on Laboratory Animal Care Committee. Mouse lines were
obtained from JAX Mice: Fabp4-Cre, stock #005069 (He et al.,
2003); Prrx1-Cre, stock #005584 (Logan et al., 2002); PdgfRa-Cre,
stock #013148 (Roesch et al., 2008); and Rosa-EYFP, stock
#006148 (Srinivas et al., 2001). Hemizygous male Cre mice for
each line were crossed to homozygous female Rosa-EYFP indicator
mice, and both male and female progeny were analyzed.
Preparation of SVF and BMSC Cultures
Animals were euthanized by asphyxiation with CO2 and cervical
dislocation, and adipose depots were excised. Tissues were minced
and incubated in1mg/ml collagenase (Worthington) inDulbecco’s
modified Eagle’s medium (DMEM)/F12 for 1 hr at 37C with 5%
CO2. After inactivation of the digest with an equal volume of
DMEM/10%fetal bovine serum(FBS), sampleswerepassed through
a 100 mm cell strainer. For cell culture, samples were centrifuged at
300 g for 5min, and the resulting SVFwas resuspended in complete
media (DMEM/10% FBS/1% penicillin/streptomycin) and plated
for imaging or differentiation. For BMSCs, the femurs and tibia
were flushedwith completemedia. Theflushed cellswere triturated
briefly, resuspended in additional complete media, and then
cultured for imaging and differentiation. Adipogenic induction
was carried out as described (Costa et al., 2011).
Flow Cytometry and Fluorescence-Activated Cell
Sorting
Antibodies used include SCA1 Pacific Blue (BioLegend, 108120),
CD45 PE-Cy7 (eBioscience, 25-0421-82), CD11b APC-Cy7
(BioLegend, 101226), and CD31 APC (eBioscience, 17-0311-82).
SVF was prepared as for cell culture, except that following centrifu-
gation, the resulting cell pelletwas resuspended in 1mlACKLysing
Buffer (Invitrogen) to remove red blood cells. After inactivation
with Hank’s balanced salt solution (HBSS)/2% FBS, samples were
centrifuged again and resuspended in HBSS/2% FBS for antibody
labeling for flow cytometry or fluorescence-activated cell sorting
(FACS). Samples were analyzed on a BD LSR Fortessa analyzer or
sorted on a BD FACS Aria II. Cell gating was based on comparison
with unstained and fluorescence-minus-one-stained controls. Sin-
gle live cells were discriminated by forward-scatter and side-scatter
analysis and 7-AAD labeling (BD Bioscience), respectively. Cells
were sorted into serum-freeDMEMmedia for gene expression anal-
ysis or into complete media for cell culture. Flow cytometry stan-
dard files were analyzed using FlowJo version 10.
Histological Analysis
Antibodies used include chicken anti-GFP (Aves, GFP-1020), rabbit
anti-Perilipin (Sigma, P1998), and rat anti-CD31 (BD Bioscience,1156 Stem Cell Reports j Vol. 3 j 1147–1158 j December 9, 2014 j ª2014 Th553370). Mice were transcardially perfused with PBS followed by
4% formaldehyde in PBS. Tissues were excised and fixed overnight,
cryoprotected in 30% sucrose in PBS, then frozen in OCT (Sakura),
and stored at 80C. Cryosections (10 mm) were prepared using a
Leica cryostat and mounted on SuperfrostPlus sides (Fisher). After
drying, sections were blocked with 5% bovine serum albumin,
followed by labeling with primary antibody for 1 hr at room tem-
perature. After five washes with PBS/0.1% Triton X-100, sections
were incubated with appropriate secondary antibodies (goat
antichicken Alexa 488, A11039; goat antirat Alexa 647, A21247;
goat antirabbit 647, A21244; all from Invitrogen) for 30 min at
room temperature. Following additional washes, coverslips were
mounted with DAPI antifade reagent (Vector Labs) and sealed
with clear nail polish. Images were obtained using inverted Leica
epifluorescence microscope, pseudocolored using ImageJ, and
merged in Photoshop CS4 (Adobe Creative Suites).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and three figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2014.10.009.
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